Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 31, 2022Frontiers in ImmunologyOpen Access

Complement System: An Immunotherapy Target in Colorectal Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ITIman M. TalaatNENoha Mousaad ElemamMSMaha Saber-Ayad

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Talaat et al. (2022) studied this question.

synapsesocial.com/papers/6a157989d64fa333899fb64ahttps://doi.org/10.3389/fimmu.2022.810993
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Complement in Tumourigenesis and the Response to Cancer Therapy2021 · 41 citations
  2. 2Eculizumab reduces complement activation, inflammation, endothelial damage, thrombosis, and renal injury markers in aHUS2015 · 202 citations
  3. 3Genetic and Pharmacologic Inhibition of Complement Impairs Endothelial Cell Function and Ablates Ovarian Cancer Neovascularization2012 · 131 citations
  4. 4Complement component C3 – The “Swiss Army Knife” of innate immunity and host defense2016 · 504 citations